Dr. Bozaite-Gluosniene's team noted that those who took methotrexate or anti-TNFs developed fewer new cases of CAD than those who did not.
Bozaite - Gluosniene博士的研究小组指出，那些服用甲氨蝶呤或抗肿瘤坏死因子的患者发生CAD的几率比那些没有服用的患者少。
Dr. Bozaite-Gluosniene's team noted that those who took methotrexate or anti-TNFs developed fewer new cases of CAD than those who did not.
Bozaite - Gluosniene博士的研究小组指出，那些服用甲氨蝶呤或抗肿瘤坏死因子的患者发生CAD的几率比那些没有服用的患者少。
应用推荐